Search research articles
Contact Us
Filters
Showing results (21-30 of 128) with videos related to
Page
of 13
Sort By:
Cancer Immunology, Immunotherapy : CII
|
January 1, 1984
The therapeutic significance of concomitant antitumor immunity. II. Passive transfer of concomitant immunity with Ly-1+2- T cells primes established tumors in T cell-deficient recipients for endotoxin-induced regression
R J North
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1978
The concept of the activated macrophage
R J North
Infection and Immunity
|
July 1, 1974
T cell dependence of macrophage activation and mobilization during infection with Mycobacterium tuberculosis
R J North
Infection and Immunity
|
September 1, 1974
Inflammatory lymphocyte in cell-mediated antibacterial immunity: factors governing the accumulation of mediator T cells in peritoneal exudates
R J North, G Spitalny
Immunology
|
September 1, 1990
Elimination of cycling CD4+ suppressor T cells with an anti-mitotic drug releases non-cycling CD8+ T cells to cause regression of an advanced lymphoma
R J North, M Awwad
The Journal of Experimental Medicine
|
October 1, 1986
T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity
A DiGiacomo, R J North
Immunology
|
March 1, 1987
Subtherapeutic numbers of tumour-sensitized, L3T4+, Ly 1+2- T cells are needed for endotoxin to cause regression of an established immunogenic tumour
A Digiacomo, R J North
International Journal of Cancer
|
February 15, 1986
Immunological consequences of tumor excision: from active immunity to immunological memory
I Bursuker, R J North
The Journal of Experimental Medicine
|
March 1, 1996
Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis
E Medina, R J North
Trends in Microbiology
|
December 10, 1998
How important is Nramp1 in tuberculosis?
R J North, E Medina
Page
of 13
Search research articles
Search
Showing results (21-30 of 128) with videos related to
Sort By:
Page
of 13
Cancer Immunology, Immunotherapy : CII
|
January 1, 1984
The therapeutic significance of concomitant antitumor immunity. II. Passive transfer of concomitant immunity with Ly-1+2- T cells primes established tumors in T cell-deficient recipients for endotoxin-induced regression
R J North
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1978
The concept of the activated macrophage
R J North
Infection and Immunity
|
July 1, 1974
T cell dependence of macrophage activation and mobilization during infection with Mycobacterium tuberculosis
R J North
Infection and Immunity
|
September 1, 1974
Inflammatory lymphocyte in cell-mediated antibacterial immunity: factors governing the accumulation of mediator T cells in peritoneal exudates
R J North, G Spitalny
Immunology
|
September 1, 1990
Elimination of cycling CD4+ suppressor T cells with an anti-mitotic drug releases non-cycling CD8+ T cells to cause regression of an advanced lymphoma
R J North, M Awwad
The Journal of Experimental Medicine
|
October 1, 1986
T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity
A DiGiacomo, R J North
Immunology
|
March 1, 1987
Subtherapeutic numbers of tumour-sensitized, L3T4+, Ly 1+2- T cells are needed for endotoxin to cause regression of an established immunogenic tumour
A Digiacomo, R J North
International Journal of Cancer
|
February 15, 1986
Immunological consequences of tumor excision: from active immunity to immunological memory
I Bursuker, R J North
The Journal of Experimental Medicine
|
March 1, 1996
Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis
E Medina, R J North
Trends in Microbiology
|
December 10, 1998
How important is Nramp1 in tuberculosis?
R J North, E Medina
Page
of 13